Trump drafts executive order targeting China’s experimental drug dominance

Watch Trump drafts executive order targeting China’s experimental drug dominance - Straight Arrow News on Dailymotion

Transcript

00:00The Trump administration is weighing restrictions on drugs from China,

00:04a move that supporters say would strengthen national security,

00:08but critics warn could cut off access to potentially life-saving treatments.

00:15A draft executive order obtained by the New York Times shows the White House is considering

00:20limiting China's dominance in medication manufacturing. The plan would largely target

00:27experimental medicines developed in China, although it would reportedly also cover

00:32generic versions of more commonplace drugs. Backers of the idea, including investors with

00:38close ties to President Trump, argue China's biotech boom is a threat to U.S. innovation.

00:45But global drug makers such as Pfizer have urged caution, warning that a full cutoff from China

00:52could delay or deny U.S. patients from promising new treatments. The debate comes as lawmakers from

00:59both parties have raised concerns about relying on China for medicine. Trump has pushed to boost

01:06U.S. production through an August executive order and has threatened tariffs on Chinese drug imports.

01:13White House officials say the draft is just that, simply a draft proposal and is not being

01:19actively considered. The behind-the-scenes discussions and input from investors over

01:25the draft continue, according to sources who spoke with the Times. The proposal calls for increasing

01:31domestic production of antibiotics and pain relievers, with the government giving preference

01:38to American-made medicines and offering tax breaks to companies that bring pharmaceutical

01:44manufacturing back to the U.S.

01:48Thank you for watching our news update. We'll continue to follow this story and you can too

01:52by downloading the Street Arrow News mobile app today.